CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid‑in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balances (in shares) at Dec. 31, 2023		33,437,296
Beginning balances at Dec. 31, 2023	$ 242,360	$ 3	$ 437,132	$ 195	$ (194,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		30,888
Issuance of common stock upon exercise of stock options	206		206
Vesting of early exercised options (in shares)		3,411
Vesting of early exercised options	13		13
Vesting of restricted stock units (in shares)		132,458
Stock‑based compensation	3,733		3,733
Other comprehensive income (loss)	(441)			(441)
Net (loss) income	23,496				23,496
Ending balances (in shares) at Mar. 31, 2024		33,604,053
Ending balances at Mar. 31, 2024	269,367	$ 3	441,084	(246)	(171,474)
Beginning balances (in shares) at Dec. 31, 2023		33,437,296
Beginning balances at Dec. 31, 2023	$ 242,360	$ 3	437,132	195	(194,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of early exercised options (in shares)	1,676
Ending balances (in shares) at Dec. 31, 2024	37,574,538	37,574,538
Ending balances at Dec. 31, 2024	$ 428,678	$ 4	558,061	(43)	(129,344)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	40,984	40,984
Issuance of common stock upon exercise of stock options	$ 350		350
Vesting of early exercised options (in shares)	0	1,676
Vesting of early exercised options	$ 14		14
Vesting of restricted stock units (in shares)		325,085
Stock‑based compensation	5,087		5,087
Other comprehensive income (loss)	480			480
Net (loss) income	$ (17,349)				(17,349)
Ending balances (in shares) at Mar. 31, 2025	37,942,283	37,942,283
Ending balances at Mar. 31, 2025	$ 417,260	$ 4	$ 563,512	$ 437	$ (146,693)